RedHill Biopharma Ltd.

RDHL chart

RedHill Biopharma Ltd. news

• RDHL Q2 2022 Earnings: Per-ADS Loss of $200 Widely Misses Estimates, Yet Shares Edge Higher - Revenue Recognition Risk

  www.dars.gov.et · Oct 24, 8:46 AM EDT

• Redhill Biopharma Ltd. Estimates – NASDAQ:RDHL

  TradingView · Oct 23, 5:27 PM EDT

• RDHL Forecast — Price Target — Prediction for 2027

  TradingView · Oct 23, 4:29 AM EDT

• Drug rights return to RedHill Biopharma (RDHL) as Hyloris agrees to a $200,000 break-up fee.

  Stock Titan · Oct 21, 7:00 AM EDT

• $2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma

  Yahoo Finance · Oct 19, 8:00 AM EDT

• Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet

  Yahoo Finance · Oct 1, 3:12 PM EDT

• RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results

  Yahoo Finance · Sep 30, 4:05 PM EDT

• RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties?

  Yahoo Finance · Sep 10, 12:06 PM EDT

• RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

  Yahoo Finance · Sep 1, 7:00 AM EDT

• Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight

  Yahoo Finance · Aug 31, 1:00 PM EDT

• Redhill Biopharma Stock Doubles In One Session — Here's Why

  Yahoo Finance · Aug 31, 10:06 AM EDT

• RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

  Yahoo Finance · Aug 31, 7:00 AM EDT

RedHill Biopharma Ltd. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-21
• 6-K6-K2026-10-19
• 6-K6-K2026-10-13
• 6-K6-K2026-10-07
• 6-K6-K2026-09-30
• 6-K6-K2026-09-30
• 6-K6-K2026-09-01
• 6-K6-K2026-08-31
• 6-K6-K2026-08-07
• 6-K6-K2026-08-06
• 6-K6-K2026-07-28
• 6-K6-K2026-07-01

About RedHill Biopharma Ltd.

Ticker

RDHL (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Tel Aviv, Israel

Incorporated in

Israel

SEC CIK

1553846

Frequently asked questions